<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30247208</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-0229</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>43</Volume>                    <Issue>11</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Clinical nuclear medicine</Title>                <ISOAbbreviation>Clin Nucl Med</ISOAbbreviation>            </Journal>            <ArticleTitle>68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma.</ArticleTitle>            <Pagination>                <MedlinePgn>e414-e416</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/RLU.0000000000002265</ELocationID>            <Abstract>                <AbstractText>Primary signet ring cell adenocarcinoma of the breast is a rare neoplasm. Similar to other mucinous neoplasms, it has low FDG avidity and poor prognosis compared with the traditional ductal/lobular carcinomas. We present a case of a 40-year-old woman with signet ring cell adenocarcinoma and skeletal fluorosis showing higher uptake of Ga-prostate-specific membrane antigen in the primary lesion and the metastatic sites compared with F-FDG on PET/CT imaging. Additionally, diffuse increased prostate-specific membrane antigen uptake was noticed in the entire skeleton, likely due to skeletal fluorosis.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Parihar</LastName>                    <ForeName>Ashwin Singh</ForeName>                    <Initials>AS</Initials>                    <AffiliationInfo>                        <Affiliation>From the Department of Nuclear Medicine &amp; PET and.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mittal</LastName>                    <ForeName>Bhagwant Rai</ForeName>                    <Initials>BR</Initials>                    <AffiliationInfo>                        <Affiliation>From the Department of Nuclear Medicine &amp; PET and.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sood</LastName>                    <ForeName>Apurva</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>From the Department of Nuclear Medicine &amp; PET and.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Basher</LastName>                    <ForeName>Rajender Kumar</ForeName>                    <Initials>RK</Initials>                    <AffiliationInfo>                        <Affiliation>From the Department of Nuclear Medicine &amp; PET and.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Singh</LastName>                    <ForeName>Gurpreet</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>General Surgery Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Clin Nucl Med</MedlineTA>            <NlmUniqueID>7611109</NlmUniqueID>            <ISSNLinking>0363-9762</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30247208</ArticleId>            <ArticleId IdType="doi">10.1097/RLU.0000000000002265</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>